VLX Ventures

A venture capital firm and technological incubator based in Jerusalem, Israel, focusing on biopharma and digital pharma.

Incubator Active Jerusalem, Israel Est. 2013
Visit website ↗ LinkedIn
Last updated 2026-07-20
Portfolio
15
in our dataset
Rounds participated
19
Rounds led
0
Rounds' value
$15.9M
total disclosed, rounds participated
Stages
Pre-Seed, Seed

About

VLX Ventures is a venture capital firm and technological incubator based in Jerusalem, Israel. It was founded as a partnership between Xenia Venture Capital and Van Leer Ventures. VLX Ventures operates under a government-licensed incubator status, allowing it to access co-funding from the Israel Innovation Authority. The firm focuses on drug development and computational biology, primarily investing in biopharma therapeutic ventures and digital pharma initiatives that integrate deep biology with computational biology. VLX Ventures supports startups through intensive research and development, business validation, and the establishment of innovative companies, aiming to transform ideas into impactful realities.

Portfolio · 15

Tamarix Pharma
Therapies for Apoptosis-driven Diseases
1 round Latest: 2021-01
Pyxis Diagnostics
AI-powered Cancer Diagnostics Platform for Predicting Immuno-oncology Drug Response
1 round $1.2M committed Latest: 2019-09
Shoodoo Analytics
Predictive Analytics for Precise Business Answers
2 rounds $1.6M committed Latest: 2019-03
Oddetect
Video Analytics Software for Video Surveillance Systems
1 round $900K committed Latest: 2018-10
Quze
AI-driven Optimization Solution for Queue Management
1 round $750K committed Latest: 2018-07
TPCera
Immunomodulatory Treatment for Autoimmune Diseases
2 rounds $3.8M committed Latest: 2018-07
Camereyes
Deep-learning Imaging Platform to Prevent Diabetic Retinopathy
2 rounds $950K committed Latest: 2018-04
Comroads
Dash Cam Sharing Platform
1 round $880K committed Latest: 2018-01
Meeter
Meeting Scheduling App
2 rounds $1.6M committed Latest: 2016-01
TPM Medical
Treatment for Chronic Pain
1 round $600K committed Latest: 2015-12
Akross
Location-based Event Discovery App
1 round $500K committed Latest: 2015-11
I Am Real
User Identity Verification Services
1 round $700K committed Latest: 2014-07
Laryngoport
Flexible Endoscopic Platform for Laryngeal Microsurgery
1 round $1.0M committed Latest: 2012-01
Keren Medical
Automatic Suturing Device for Prostate Anastomosis
1 round $600K committed Latest: 2012-01
OriginGPS
Miniature GNSS Modules and Cellular IoT Systems
1 round $900K committed Latest: 2006-12

Investment activity

Portfolio by sector

Health Tech & Life Sciences14
Business Software4
Automotive & Mobility Technologies2
Cyber Security2
Agriculture & Food Technologies1
Aerospace, Defense & HLS1
Industrial Technologies1

Q&A

What is VLX Ventures' primary investment focus?
VLX Ventures primarily invests in early-stage data-driven, biotechnology, and pharma companies, as well as digital pharma, often utilizing notions from two or more of these domains.
What investment stages does VLX Ventures target?
VLX Ventures targets Pre-Seed and Seed stage investments.
What is the typical check size for VLX Ventures' seed investments?
VLX Ventures' seed investments typically range from $700K to $1M.
Can you name some of VLX Ventures' portfolio companies in the Health Tech & Life Sciences sector?
VLX Ventures has invested in companies such as EyeYon Medical, which develops ophthalmic products, and Omnix Medical, which focuses on novel antibiotic agents.
Which sector has received the most investment rounds from VLX Ventures?
Health Tech & Life Sciences has received the most investment rounds from VLX Ventures, with 17 rounds.
What is a notable exit for VLX Ventures?
VLX Ventures had an exit with Secure Islands, a company focused on comprehensive data immunization technology, which was acquired.
When was VLX Ventures founded?
VLX Ventures was founded in 2013.
Who are some of the key team members at VLX Ventures?
Key team members at VLX Ventures include Ori Choshen, CEO, and Dr. Lior Carmon, CIO.
Has VLX Ventures made any recent investments in the Health Tech & Life Sciences sector?
Yes, VLX Ventures invested in Sakura Bio, an allogeneic cell therapy platform, in July 2022, and Pyxis Diagnostics in September 2019.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)